To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
In this chapter we cover both polycythemia and fetomaternal hemorrhage. In the former, the hematocrit and blood volume are generally increased, whereas in the latter, both are generally very low. In both conditions, however, there is concern about inadequate organ blood flow, oxygen delivery, and potential for hypoxic injury, especially in the brain. A large body of definitive information on polycythemia is available that allows conclusions to be made as to management and patient outcome. However, the area of fetomaternal hemorrhage has not been as comprehensively investigated and relies mostly on small clinical series and case reports. There are no controlled basic or clinical trials, which hampers our understanding of pathophysiology as well as therapeutic modalities. This leaves us with gaps in our knowledge of this important topic. What is presented here is the most current body of information and recommendations for diagnosis, treatment, and reported outcomes.
1. Hyperleukocytosis may be the first presentation of acute myeloid leukemias and prognosticates high morbidity and mortality making immediate therapy imperative.
2. Neurologic deficits, respiratory failure with pulmonary infiltrates, fever and visual changes are frequent presentations of hyperleukocytosis due to leukocyte infiltrates or vessel occlusion. Antibiotics are warranted although the etiology may not be infectious.
3. Hyperleukocytosis can result in other oncologic emergencies such as leukostasis, tumor lysis syndrome, and/or disseminated intravascular coagulation involving multiple organ systems. Evaluation and work up should be directed by symptoms; consider evaluation for intracranial hemorrhage.
4. Differentiate between the true hyperkalemia of tumor lysis syndrome and pseudohyperkalemia of hyperleukocytosis with ECG and a heparinized plasma sample before treating.
5. Urgent cytoreduction with Hydroxyurea (Hydrea) and/or leukapheresis may need to be initiated in parallel to induction chemotherapy. If necessary, transfer to an institution that is able to provide these services immediately.
Mesh-Free FD Approximations are easy to work with and are in some sense optimal in their representations of functions locally around a single point. However, in more than one dimension, approximations based on polynomial interpolants encounter severe difficulties if the node points are not regularly placed (grid-based). Additional difficulties often arise at boundaries which (above 1-D) may be irregularly shaped, and also from mixtures of scales across a computational domain that may require spatially variable resolution. It transpires that radial basis functions (RBFs) can favorably replace (or supplement) polynomials in such situations. Their use in creating spatially local and highly effective FD-type approximations is quite recent.
The association of elevated hematocrit and fibrinogen levels with increased stroke risk has led to continued interest in hemorheologic factors and their role in the development of vascular disease and acute stroke. Viscosity increases logarithmically at the lowest shear rates and this effect is magnified at higher hematocrit levels. Fibrinogen may play a causal role in ischemic stroke through several mechanisms. The most prominent of these is its essential role in thrombosis, both as the substrate for fibrin clot formation and as a facilitator of platelet aggregation. The risk of stroke in sickle cell disease (SCD) varies according to genotype and is highest in patients with homozygous SS. Plasma hyperviscosity syndromes are treated by plasmapheresis (plasma exchange) to remove the paraproteins and thereby reduce hyperviscosity and hypervolemia. Newer techniques of cell centrifugation, plasma separation, and filtration may also be useful.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.